Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Cream for Primary Premature Ejaculation
NCT05749614Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of lidocaine 10% oropharyngeal spray in premature ejaculation (PE), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Arabic Index of Premature Ejaculation at 4 weeks. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT05749614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05749614.